Nexus Surgical and Medicare Limited (BOM:538874)
19.49
+1.30 (7.15%)
At close: Aug 21, 2026
BOM:538874 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 107 | 88 | 90 | 74 | 47 | 41 | |
Market Cap Growth | 7.38% | -2.79% | 22.33% | 55.84% | 14.72% | 118.55% |
Enterprise Value | 101 | 86 | 89 | 67 | 43 | 41 |
Last Close Price | 19.49 | 16.03 | 16.49 | 13.48 | 8.65 | 7.54 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.53 | 11.92 | 18.14 | 34.58 | 27.73 | 14.22 |
PS Ratio | 1.23 | 1.12 | 1.58 | 2.12 | 3.05 | 1.72 |
PB Ratio | 5.93 | 4.87 | 8.48 | 13.03 | 13.41 | 22.64 |
P/TBV Ratio | 5.93 | 4.87 | 8.48 | 13.03 | 13.41 | 22.64 |
P/FCF Ratio | 61.61 | 50.67 | 92.89 | - | 8.71 | - |
P/OCF Ratio | 61.61 | 50.67 | 86.55 | - | 8.61 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.16 | 1.09 | 1.56 | 1.93 | 2.80 | 1.70 |
EV/EBITDA Ratio | 10.07 | 8.89 | 13.40 | 25.27 | 20.07 | 11.04 |
EV/EBIT Ratio | 10.11 | 8.93 | 13.48 | 25.45 | 20.20 | 11.12 |
EV/FCF Ratio | 58.45 | 49.47 | 91.68 | - | 8.00 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Debt / Equity Ratio | -0.30 | -0.30 | -0.35 | -0.49 | -1.96 | -0.82 |
Net Debt / EBITDA Ratio | -0.53 | -0.57 | -0.56 | -1.04 | -3.20 | -0.41 |
Net Debt / FCF Ratio | - | -3.16 | -3.85 | 0.66 | -1.28 | 1.35 |
Asset Turnover | - | 2.66 | 2.80 | 2.55 | 1.06 | 1.63 |
Inventory Turnover | - | 6.16 | 4.50 | 2.51 | 1.83 | - |
Quick Ratio | - | 1.01 | 1.41 | 0.83 | 1.31 | 0.08 |
Current Ratio | - | 1.96 | 1.85 | 1.41 | 1.57 | 0.99 |
Return on Equity (ROE) | - | 51.41% | 61.03% | 46.41% | 63.79% | 781.39% |
Return on Assets (ROA) | - | 20.24% | 20.23% | 12.12% | 9.21% | 15.54% |
Return on Invested Capital (ROIC) | 61.19% | 73.61% | 100.45% | - | - | - |
Return on Capital Employed (ROCE) | - | 53.30% | 62.10% | 46.60% | 61.00% | 200.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 7.39% | 8.39% | 5.51% | 2.89% | 3.61% | 7.03% |
FCF Yield | 1.62% | 1.97% | 1.08% | -5.65% | 11.48% | -2.71% |
Buyback Yield / Dilution | -0.88% | 0.35% | - | - | - | - |